Science Exchange, the world’s leading marketplace for R&D
services, announced a collaboration with Atlas Genomics to offer online access to its Contract Research services, including singleplex and multiplex immunoassays (Luminex, MSD), gene expression analysis (Quantigene), Next Generation Sequencing, qPCR, and more, to research scientists.
Atlas Genomics is a Seattle-based, high complexity, CLIA-certified company whose mission is to provide the highest quality CRO data services in parallel with a superior level of customer service through client collaboration.
About Atlas Genomics
Atlas Genomics is a CLIA-certified, molecular diagnostic laboratory and CRO (contract research organization) founded in 2014 and located in Seattle, Washington.
We offer a multitude of CRO capabilities including Next Generation Sequencing (Illumina); qPCR (Taqman); multiplexed DNA, RNA, and protein analysis (Luminex, MSD); and ELISA. Our highlighted multiplex platforms include ProcartaPlex™ and QuantiGene™ Plex (ThermoFisher Scientific), MILLIPLEX® MAP (MilliporeSigma), High Performance and Luminex Immunoassays from R&D Systems, and v-Plex™ (MSD), which enables measurement of 1-80 targets in a single well.
We are currently working with several top drug discovery firms, partnering to ensure their non-clinical and clinical project timelines are on schedule and within budget. A key component of our laboratory is our unique and personal commitment to our biotechnology partners, which provides them the highest quality data at a fraction of the time offered by other laboratories.
Our tenured laboratory staff is nimble, attentive, and informative — and we keep our valued clients informed of progress every step of the way. When looking for a reliable and trustworthy partner, look to Atlas Genomics.